+1 (314) 370-6046 oderKontakt

Anti-TFPI Antikörper (A323369)

Monoklonal Human Antikörper gegen TFPI für ELISA, FACS, Functional Assay und In Vivo.

Versandkosten
Vorlaufzeit
Lieferung in 7-10 Werktagen
Telefon
+1 (314) 370-6046
Mo bis Frei, 8am - 4pm AST
Email
orders@antibodies.com
Produktname
Concizumab Biosimilar - Anti-TFPI Antibody - Low endotoxin, Azide free
Beschreibung
Recombinant human monoclonal antibody to TFPI.
Anwendungen
ELISA, FACS, Functional Assay, In Vivo
Reaktivität
Human, Rhesus Macaque, Rabbit
Wirt
Human
Klonalität
Monoclonal
Isotyp
IgG4SP - Human IgG4 with S228P mutation
Leichte Ketten
kappa
Konjugat

Unconjugated

Reinigung
Protein A affinity chromatography.
Konzentration
Reconstitution dependent.
Molekulargewicht
This antibody has a predicted MW of 145 kDa.
Reinheit
> 95% (by SDS-PAGE and SEC-HPLC).
Produktform
Lyophilized
Rekonstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulierung
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Lagerung
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyme
Anti convertin, EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein associated coagulation inhibitor, Lipoprotein-associated coagulation inhibitor, TFI, TFPI 1, TFPI1, TFPI1_HUMAN, Tissue factor pathway inhibitor, Tissue factor pathway inhibitor (lipoprotein associated coagulation inhibitor)
Haftungsausschluss
Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.

Alternative Produkte zum Anti-TFPI Antikörper (A323369)

Oben